Back to news

Why Medpace Holdings (MEDP) Stock Is Up Today

Investivoq PriceTracker

Medpace Holdings (MEDP) is up 5.5% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver appears to be investor positioning ahead of Medpace’s third-quarter 2026 earnings report, which is scheduled for after the market close on October 21, 2026. The move may also reflect continued optimism after a strong midyear performance and a series of higher Wall Street price targets in recent months, although there does not appear to be a single new company announcement driving the jump during the session.

Details:

  • Medpace previously announced that it would release third-quarter 2026 results after the close on October 21, 2026, putting the stock in focus for an earnings-related move.
  • In second-quarter 2026 results, Medpace posted revenue growth of 17.2% year over year to $707.3 million and net new business awards growth of 28.2%, showing solid operating momentum heading into this report.
  • Recent analyst actions have trended more constructive, including higher price targets over the past few months and an upgrade to Neutral from Sell in late September.
  • Recent SEC filings also show insider selling by the chief executive in late September and early October, so today’s gain looks more tied to earnings expectations and sentiment than to insider activity.

    • Sources:

    Medpace investor relations, SEC, StockAnalysis

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $MEDP Insider Trading Activity

    MEDP Insider Trades

    $MEDP insiders have traded $MEDP stock on the open market 32 times in the past 6 months. Of those trades, 0 have been purchases and 32 have been sales.

    Here’s a breakdown of recent trading of $MEDP stock by insiders over the last 6 months:

    • AUGUST J. TROENDLE (President & CEO) has made 0 purchases and 24 sales selling 307,959 shares for an estimated $190,851,138.
    • STEPHEN P EWALD (General Counsel & Corp. Secy.) sold 16,349 shares for an estimated $7,357,050
    • SUSAN E BURWIG (Exec. VP, Operations) sold 7,500 shares for an estimated $4,500,000
    • FRED B JR DAVENPORT sold 7,283 shares for an estimated $4,414,590
    • BRIAN T CARLEY sold 5,000 shares for an estimated $3,043,150
    • ROBERT O. KRAFT sold 3,858 shares for an estimated $2,383,510
    • KEVIN M. BRADY (CFO & Treasurer) sold 3,400 shares for an estimated $2,125,816
    • CORNELIUS P. III MCCARTHY has made 0 purchases and 2 sales selling 1,935 shares for an estimated $1,155,253.

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    EARLY ACCESS
    Receive MEDP Data Alerts
    Real-time alerts on filings, insider trades, and market signals — before everyone else.
    Get Alerts →

    $MEDP Hedge Fund Activity

    We have seen 286 institutional investors add shares of $MEDP stock to their portfolio, and 387 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • PRICE T ROWE ASSOCIATES INC /MD/ added 1,780,170 shares (+614.9%) to their portfolio in Q2 2026, for an estimated $942,760,230
    • D. E. SHAW & CO., INC. removed 293,695 shares (-55.6%) from their portfolio in Q2 2026, for an estimated $155,537,935
    • JPMORGAN CHASE & CO added 214,912 shares (+inf%) to their portfolio in Q2 2026, for an estimated $113,815,246
    • SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 211,847 shares (+inf%) to their portfolio in Q2 2026, for an estimated $112,192,052
    • MAWER INVESTMENT MANAGEMENT LTD. removed 178,929 shares (-40.1%) from their portfolio in Q2 2026, for an estimated $94,759,009
    • WASATCH ADVISORS LP removed 170,651 shares (-26.8%) from their portfolio in Q3 2026, for an estimated $106,516,941
    • TWO SIGMA INVESTMENTS, LP removed 166,817 shares (-94.5%) from their portfolio in Q2 2026, for an estimated $88,344,615

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $MEDP Congressional Stock Trading

    Members of Congress have traded $MEDP stock 2 times in the past 6 months. Of those trades, 2 have been purchases and 0 have been sales.

    Here’s a breakdown of recent trading of $MEDP stock by members of Congress over the last 6 months:

    • REPRESENTATIVE DAVID TAYLOR has traded it 2 times. They made 2 purchases worth up to $30,000 on 05/15 and 0 sales.

    To track congressional stock trading, check out Investivoq's congressional trading dashboard. You can access data on congressional stock trades through the Investivoq API Congress trades endpoint.

    $MEDP Price Targets

    Multiple analysts have issued price targets for $MEDP recently. We have seen 2 analysts offer price targets for $MEDP in the last 6 months, with a median target of $531.0.

    Here are some recent targets:

    • Eric Coldwell from Baird set a target price of $547.0 on 07/08/2026
    • David Windley from Jefferies set a target price of $515.0 on 07/07/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.